The inhibitory GABA system as a therapeutic target for cognitive symptoms in schizophrenia: investigational agents in the pipeline.
about
Early interventions in risk groups for schizophrenia: what are we waiting for?Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes.Brain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of (1) H-MRS studies.Increases in [3H]muscimol and [3H]flumazenil binding in the dorsolateral prefrontal cortex in schizophrenia are linked to α4 and γ2S mRNA levels respectively.The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disordersBenzodiazepine receptor ligands: a patent review (2006-2012).The neurobiology and treatment of first-episode schizophrenia.Novel treatment strategies for schizophrenia from improved understanding of genetic risk.Cognitive deficits caused by prefrontal cortical and hippocampal neural disinhibition.Is the GABA System Related to the Social Competence Improvement Effect of Aripiprazole? An (18)F-Fluoroflumazenil PET Study.Listening to Sentences in Noise: Revealing Binaural Hearing Challenges in Patients with Schizophrenia.GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.Reducing inhibition: A promising new strategy for the treatment of schizophrenia
P2860
Q26747545-0B0C778A-274B-4326-BBF9-397EE966B2F6Q28080944-737AB184-0704-4CC0-B0A1-9FF0E59B680EQ30466591-8A2385DA-6AB6-45DF-A518-28B019E5BA87Q31090438-C97EA97B-5CAD-46C4-8235-69CD0CB8F982Q34548202-8A6295E5-38BA-4E88-8D2A-702A146B5869Q36917104-A3AC4C7E-F5A1-40AE-A124-DB123A27FA00Q38092169-1303598C-A990-4465-9FDA-027CE671D2B1Q38232366-3569F4EB-10A1-4719-9F90-FE2D009D028EQ38241786-16B2A7E3-215C-470A-A571-7632B55D7F77Q39287296-B52AB461-20F5-47E9-A07E-17C9284350F4Q41513402-EB5FF1E1-B45E-43EA-AE58-E4F7D882CB48Q47132589-13E4BA8B-889B-438D-BF1A-D6969DC60F51Q53428761-27ED4983-D276-4382-AC4F-CD15F3C42285Q58766522-F4F720A2-575C-405C-AF89-14FBB142EC53
P2860
The inhibitory GABA system as a therapeutic target for cognitive symptoms in schizophrenia: investigational agents in the pipeline.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The inhibitory GABA system as ...... tional agents in the pipeline.
@en
The inhibitory GABA system as ...... tional agents in the pipeline.
@nl
type
label
The inhibitory GABA system as ...... tional agents in the pipeline.
@en
The inhibitory GABA system as ...... tional agents in the pipeline.
@nl
prefLabel
The inhibitory GABA system as ...... tional agents in the pipeline.
@en
The inhibitory GABA system as ...... tional agents in the pipeline.
@nl
P2093
P2860
P1476
The inhibitory GABA system as ...... tional agents in the pipeline.
@en
P2093
Berend Olivier
Christiaan H Vinkers
Naheed R Mirza
P2860
P304
P356
10.1517/13543784.2010.513382
P407
P50
P577
2010-10-01T00:00:00Z